Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT00778908 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

RADIATION: Late-course accelerated hyperfractionated IMRT
DRUG: Concomitant cisplatin chemotherapy
RADIATION: Conventionally fractionated IMRT

Sponsor

Guangxi Medical University

Collaborators

[object Object]
[object Object]